Surgical Oncology

Clinical Immunotherapy

Wake Forest is a leader in treating certain types of cancer using vaccines and medications, which use the body’s immune system to fight cancer. Called immunotherapy, doctors prime the body’s own immune system to fight cancer. Immunotherapy targets only the cancer cells. Chemotherapy, which attacks both cancer cells and healthy cells, can have greater side effects.

Clinical immunotherapy is administered through the melanoma program and is led by John H. Stewart IV, MD, one of our surgical oncologists, who received specialized training in immunotherapy at the National Cancer Institute.

Advanced Clinical Immunotherapy Clinical Trials 

The clinical immunotherapy program at Wake Forest participates in clinical trials. Currently, patients with metastatic melanoma and kidney (renal cell) cancers are being treated with immunotherapy, which includes the use of vaccines, interferon and Interleukin-2 and ipilimumab.

Interleukin-2 modifies the body’s immune system: it stimulates the body to produce more T-cells, which are white blood cells that fight disease. We also now offer other targeted therapies for melanoma

Investigators at Wake Forest Baptist are involved in clinical trials that are evaluating novel immunomodulators including ipilimumab and anti-cancer vaccines. Additional work is focused on viruses that treat a variety of cancers.

Quick Reference

Comprehensive Cancer Center

1st Floor Information Desk
336-713-6979
Appointments 336-716-WAKE
Toll-Free 888-716-WAKE

Find a Doctor Ways to Give
Last Updated: 03-21-2014
USNWR 2013-2014Magnet Hospital RecognitionConsumer Choice2014 Best DoctorsJoint Commission Report

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.